Provided by Tiger Trade Technology Pte. Ltd.

HANSOH PHARMA

31.640
+0.1000.32%
Volume:2.64M
Turnover:84.10M
Market Cap:191.86B
PE:29.02
High:32.580
Open:31.540
Low:31.540
Close:31.540
52wk High:43.587
52wk Low:27.658
Shares:6.06B
HK Float Shares:6.06B
Volume Ratio:0.85
T/O Rate:0.04%
Dividend:0.50
Dividend Rate:1.57%
EPS(LYR):1.090
ROE:19.40%
ROA:9.08%
PB:4.33
PE(LYR):29.02
PS:10.29

Loading ...

Hansoh Pharma's Aumolertinib Application Validated by EMA for EU Review

MT Newswires Live
·
3 hours ago

Hansoh Pharmaceutical Says it Resubmitted EU Marketing Authorization Application for Aumolertinib to Ema

THOMSON REUTERS
·
Yesterday

Hansoh Pharmaceutical Says EMA Starts Reviewing Marketing Authorization Application for Aumolertinib

Reuters
·
Yesterday

Hansoh Pharmaceutical Group Stock Sheds 2.0% in Hong Kong

Dow Jones
·
Oct 09

Hansoh Pharmaceutical Group Stock Falls 5.1% in Hong Kong

Dow Jones
·
Oct 08

Movement Alert|HANSOH PHARMA Falls 3.01% in Regular Trading, Major Shareholder Affiliates Reduced Stakes and EU Marketing Revocation for Aumolertinib

Market Focus
·
Oct 08

Does China Cancer Drug Filing Change The Bull Case For Hansoh Pharmaceutical Group (SEHK:3692)?

Simply Wall St.
·
Oct 07

Hansoh Pharmaceutical Group Stock Rises 1.7% in Hong Kong

Dow Jones
·
Oct 06

Cantrust (Far East) Limited Cuts Stake in Hansoh Pharma (03692) by 124,000 Shares at About HK$33.96 Each

Stock News
·
Oct 05

HANSOH PHARMA: JQC International Limited Disposes of Shares, Long Position Falls to 15.16%

HK Disclosure
·
Oct 05

HANSOH PHARMA: Junda Cen Disposes of Shares, Long Position Falls to 15.16%

HK Disclosure
·
Oct 05

HANSOH PHARMA: APEX MEDICAL COMPANY LTD. Disposes of Shares, Long Position Falls to 15.16%

HK Disclosure
·
Oct 05

HANSOH PHARMA: JQC Holding Limited Disposes of Shares, Long Position Falls to 15.16%

HK Disclosure
·
Oct 05

Hansoh Pharma Says Phase III Lighten Trial Shows 19.3% Weight Loss at Week 48 with Olatorepatide 15 Mg

Reuters
·
Oct 05

Major Drugmakers Turn to China for Licensing Deals

Reuters
·
Oct 02

Hansoh Pharmaceutical Group Stock Slips 3.3% in Hong Kong

Dow Jones
·
Oct 02

Hansoh Pharmaceutical Group (SEHK:3692) Could Be 30% Undervalued On Late Stage Drug Progress

Simply Wall St.
·
Oct 02

Movement Alert|HANSOH PHARMA Falls 3.97% in Regular Trading, EU Revocation of Aumolertinib Approval Continues to Weigh on Sentiment

Market Focus
·
Oct 02

Major Drugmakers Turn to China for Licensing Deals

Reuters
·
Sep 30

Hansoh Pharmaceutical Group Stock Rises 5.3% in Hong Kong

Dow Jones
·
Sep 30